Skip to main content

Find Clinical Trials

Home
Conditions
NK Cell

Clinical trial condition

NK Cell

Explore clinical trials studying NK Cell. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

NK Cell trial results

Recruiting

CD123-CD16-NK Cells Immunotherapy for AML

NCT06835140

Conditions: AML (Acute Myelogenous Leukemia), CD123+ Acute Myeloid Leukemia, Hematologic Diseases, +7 more
Locations: Chinese PLA General Hospital Beijing, China

View Trial Details

Not Yet Recruiting

A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

NCT07579208

Conditions: Astrocytoma, Chimera Antigen Receptor (CAR), EGFRvIII, +14 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.

NCT06641648

Conditions: Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse, Disease Attributes, +11 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma

NCT05909098

Conditions: B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, NK Cell
Locations: EC of Xiangyang No.1 People's Hospital Hubei University of Medicine Hubei, Xiangyang, China

View Trial Details